Cargando…

Dark chocolate or tomato extract for prehypertension: a randomised controlled trial

BACKGROUND: Flavanol-rich chocolate and lycopene-rich tomato extract have attracted interest as potential alternative treatment options for hypertension, a known risk factor for cardiovascular morbidity and mortality. Treatment of prehypertension (SBP 120–139/DBP 80–89 mmHg) may forestall progressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Ried, Karin, Frank, Oliver R, Stocks, Nigel P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712451/
https://www.ncbi.nlm.nih.gov/pubmed/19583878
http://dx.doi.org/10.1186/1472-6882-9-22
_version_ 1782169488396910592
author Ried, Karin
Frank, Oliver R
Stocks, Nigel P
author_facet Ried, Karin
Frank, Oliver R
Stocks, Nigel P
author_sort Ried, Karin
collection PubMed
description BACKGROUND: Flavanol-rich chocolate and lycopene-rich tomato extract have attracted interest as potential alternative treatment options for hypertension, a known risk factor for cardiovascular morbidity and mortality. Treatment of prehypertension (SBP 120–139/DBP 80–89 mmHg) may forestall progression to hypertension. However, there has been only limited research into non-pharmacological treatment options for prehypertension. We investigated the effect of dark chocolate or tomato extract on blood pressure, and their acceptability as an ongoing treatment option in a prehypertensive population. METHODS: Our trial consisted of two phases: a randomised controlled three-group-parallel trial over 12 weeks (phase 1) followed by a crossover of the two active treatment arms over an additional 12-week period (phase 2). Group 1 received a 50 g daily dose of dark chocolate with 70% cocoa containing 750 mg polyphenols, group 2 were allocated one tomato extract capsule containing 15 mg lycopene per day, and group 3 received one placebo capsule daily over 8 weeks followed by a 4-week washout period. In phase 2 the active treatment groups were crossed over to receive the alternative treatment. Median blood pressure, weight, and abdominal circumference were measured 4-weekly, and other characteristics including physical activity, general health, energy, mood, and acceptability of treatment were assessed by questionnaire at 0, 8 and 20 weeks. We analysed changes over time using a linear mixed model, and one time point differences using Kruskal-Wallis, Fisher's-Exact, or t-tests. RESULTS: Thirty-six prehypertensive healthy adult volunteers completed the 6-month trial. Blood pressure changes over time within groups and between groups were not significant and independent of treatment. Weight and other characteristics did not change significantly during the trial. However, a marked difference in acceptability between the two treatment forms (chocolate or capsule) was revealed (p < 0.0001). Half of the participants allocated to the chocolate treatment found it hard to eat 50 g of dark chocolate every day and 20% considered it an unacceptable long-term treatment option, whereas all participants found it easy and acceptable to take a capsule each day for blood pressure. CONCLUSION: Our study did not find a blood pressure lowering effect of dark chocolate or tomato extract in a prehypertensive population. Practicability of chocolate as a long-term treatment option may be limited. TRIAL REGISTRATION: Identifier: ACTRN12609000047291
format Text
id pubmed-2712451
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27124512009-07-18 Dark chocolate or tomato extract for prehypertension: a randomised controlled trial Ried, Karin Frank, Oliver R Stocks, Nigel P BMC Complement Altern Med Research Article BACKGROUND: Flavanol-rich chocolate and lycopene-rich tomato extract have attracted interest as potential alternative treatment options for hypertension, a known risk factor for cardiovascular morbidity and mortality. Treatment of prehypertension (SBP 120–139/DBP 80–89 mmHg) may forestall progression to hypertension. However, there has been only limited research into non-pharmacological treatment options for prehypertension. We investigated the effect of dark chocolate or tomato extract on blood pressure, and their acceptability as an ongoing treatment option in a prehypertensive population. METHODS: Our trial consisted of two phases: a randomised controlled three-group-parallel trial over 12 weeks (phase 1) followed by a crossover of the two active treatment arms over an additional 12-week period (phase 2). Group 1 received a 50 g daily dose of dark chocolate with 70% cocoa containing 750 mg polyphenols, group 2 were allocated one tomato extract capsule containing 15 mg lycopene per day, and group 3 received one placebo capsule daily over 8 weeks followed by a 4-week washout period. In phase 2 the active treatment groups were crossed over to receive the alternative treatment. Median blood pressure, weight, and abdominal circumference were measured 4-weekly, and other characteristics including physical activity, general health, energy, mood, and acceptability of treatment were assessed by questionnaire at 0, 8 and 20 weeks. We analysed changes over time using a linear mixed model, and one time point differences using Kruskal-Wallis, Fisher's-Exact, or t-tests. RESULTS: Thirty-six prehypertensive healthy adult volunteers completed the 6-month trial. Blood pressure changes over time within groups and between groups were not significant and independent of treatment. Weight and other characteristics did not change significantly during the trial. However, a marked difference in acceptability between the two treatment forms (chocolate or capsule) was revealed (p < 0.0001). Half of the participants allocated to the chocolate treatment found it hard to eat 50 g of dark chocolate every day and 20% considered it an unacceptable long-term treatment option, whereas all participants found it easy and acceptable to take a capsule each day for blood pressure. CONCLUSION: Our study did not find a blood pressure lowering effect of dark chocolate or tomato extract in a prehypertensive population. Practicability of chocolate as a long-term treatment option may be limited. TRIAL REGISTRATION: Identifier: ACTRN12609000047291 BioMed Central 2009-07-08 /pmc/articles/PMC2712451/ /pubmed/19583878 http://dx.doi.org/10.1186/1472-6882-9-22 Text en Copyright © 2009 Ried et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Ried, Karin
Frank, Oliver R
Stocks, Nigel P
Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
title Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
title_full Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
title_fullStr Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
title_full_unstemmed Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
title_short Dark chocolate or tomato extract for prehypertension: a randomised controlled trial
title_sort dark chocolate or tomato extract for prehypertension: a randomised controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2712451/
https://www.ncbi.nlm.nih.gov/pubmed/19583878
http://dx.doi.org/10.1186/1472-6882-9-22
work_keys_str_mv AT riedkarin darkchocolateortomatoextractforprehypertensionarandomisedcontrolledtrial
AT frankoliverr darkchocolateortomatoextractforprehypertensionarandomisedcontrolledtrial
AT stocksnigelp darkchocolateortomatoextractforprehypertensionarandomisedcontrolledtrial